Connect your agent Copies a setup prompt for your AI assistant

Fetch and follow the setup instructions at https://tickerinside.com/agent/prompt.md to answer questions about US ETFs, then tell me what you can now do.

IHE holdings and overlap

Edited by VoidLab Data through 2026-09-04 Page updated 2026-09-04

View as Markdown What changed

IHEiShares U.S. Pharmaceuticals ETFHealth Care, iShares, 55 positions

Last close, 2026-09-04

$104.68 -0.70%

52-week range 69 to 108

Largest position

JNJ

23.53% of the fund, Johnson & Johnson

Positions

77.6% in the ten largest

Cost per year

0.37%

$37 a year on $10,000

Assets

$1.7B

under management

Return, 3 years

+74.5%

cumulative, total return

Worst fall

-14.3%

peak to trough, 3 years, weekly closes

What does IHE hold, as of its issuer file of 2026-09-03?

IHE holds 55 positions as of the issuer file dated 2026-09-03. The three largest are Johnson & Johnson at 23.53%, Eli Lilly at 20.57% and Merck & Co Inc at 5.16%; half of the fund sits in its ten largest names.

Rank	Company	Weight
1	JNJ Johnson & Johnson	23.53%
2	LLY Eli Lilly	20.57%
3	MRK Merck & Co Inc	5.16%
4	BMY Bristol Myers Squibb	4.94%
5	RPRX Royalty Pharma PLC	4.72%
6	PFE Pfizer	4.54%
7	VTRS Viatris	4.31%
8	ZTS Zoetis Inc	3.78%
9	JAZZ Jazz Pharmaceuticals PLC	3.39%
10	ELAN Elanco Animal Health	2.66%
11	CORT Corcept Therapeutics	2.35%
12	AXSM Axsome Therapeutics	1.97%
13	LGND Ligand Pharmaceuticals	1.27%
14	DFTX Definium Therapeutics Inc	1.08%
15	LQDA Liquidia	1.05%
16	INDV Indivior Pharmaceuticals Inc	0.93%
17	OGN Organon	0.79%
18	AMLX Amylyx Pharmaceuticals	0.73%
19	TARS Tarsus Pharmaceuticals	0.72%
20	ELVN Enliven Therapeutics	0.71%
21	EWTX Edgewise Therapeutics	0.69%
22	AMRX Amneal Pharmaceuticals	0.67%
23	NKTR Nektar Therapeutics	0.56%
24	SUPN Supernus Pharmaceuticals	0.56%
25	PBH Prestige Consumer Healthcare	0.54%
26	TRVI Trevi Therapeutics	0.44%
27	PRGO Perrigo PLC	0.43%
28	MANE Veradermics	0.43%
29	OCUL Ocular Therapeutix	0.41%
30	HRMY Harmony Biosciences HLDG	0.37%
31	NUVB Nuvation Bio	0.36%
32	MBX MBX Biosciences	0.36%
33	INVA Innoviva	0.33%
34	XERS Xeris Biopharma Holdings	0.32%
35	ATAI Ataibeckley Inc	0.31%
36	OMER Omeros	0.3%
37	RAPP Rapport Therapeutics	0.3%
38	ANIP Ani Pharmaceuticals	0.29%
39	HROW Harrow	0.28%
40	LBRX LB Pharmaceuticals Inc	0.25%
41	PCRX Pacira Biosciences	0.23%
42	ALMS Alumis	0.21%
43	SEPN Septerna	0.18%
44	PAHC Phibro Animal Health Corp	0.18%
45	AMPH Amphastar Pharmaceuticals	0.18%
46	COLL Collegium Pharmaceutical	0.17%
47	MAZE Maze Therapeutics	0.16%
48	WVE Wave Life Sciences Inc	0.16%
49	TBPH Theravance Biopharma	0.14%
50	CRMD Cormedix	0.13%
51	ARVN Arvinas	0.13%
52	EOLS Evolus Inc	0.13%
53	PHAT Phathom Pharmaceuticals	0.1%
54	EYPT Eyepoint Inc	0.08%
55	BIOA Bioage Labs	0.07%

Issuer file 1 day old on 2026-09-04, against a median of 1 across the funds with a page. Every one of the 55 positions with its weight is in the fund's JSON file. See which other ETFs hold JNJ, and at what weight.

What does IHE share with other funds?

The fund nearest to IHE is XPH: the two hold 37.9% of their weight in common, in the 55 companies both own, and 100.0% of IHE itself is also held there. No covered fund holds more than that in common with IHE; it duplicates nothing here closely. IHE is close to contained in XPH.

Fund	Overlap by weight	Of IHE held there	Of that fund in IHE	Companies in both
XPH	37.9%	100.0%	91.3%	55
PJP	37.8%	75.3%	67.0%	19
IYH	36.4%	83.0%	37.1%	13
XLV	36.2%	67.1%	37.2%	7
VHT	33.4%	94.5%	33.4%	51
IXJ	26.1%	67.1%	26.2%	7
BMED	13.9%	40.6%	14.3%	6
PTH	11.9%	16.9%	19.0%	11
HDV	11.8%	14.7%	12.0%	3
XT	11.3%	62.3%	11.3%	6
RSPH	11.2%	67.1%	11.2%	7
PSCH	10.3%	10.4%	24.1%	16

From each issuer's latest file. Check IHE against any fund in the ETF overlap calculator · how overlap is measured.

What adds something different to IHE?

VDE shares 0% of weight with IHE and its weekly returns correlate with it at 0.23 over three years. The table lists the covered funds with the least in common with IHE, least shared weight first and, among equals, lowest correlation.

Fund	Name	Overlap by weight	Correlation, 3y
VDE	Vanguard Energy ETF	0.0%	0.23
VOX	Vanguard Communication Services ETF	0.0%	0.26
VPU	Vanguard Utilities ETF	0.0%	0.31
VCR	Vanguard Consumer Discretionary ETF	0.0%	0.31
VPL	Vanguard FTSE Pacific ETF	0.0%	0.36
VDC	Vanguard Consumer Staples ETF	0.0%	0.42
VIS	Vanguard Industrials ETF	0.0%	0.44
VYMI	Vanguard International High Dividend Yield ETF	0.0%	0.50

Cost, returns and risk

Expense ratio	0.37%
Dividend yield	1.42%
Total return, 1 year	49.4%
Total return, 3 years cumulative	74.5%
Total return, 5 years cumulative	80.2%
Volatility, annualised	16.7%
Worst fall, 3 years	-14.3%
Beta against SPY, 3 years of weekly returns	0.45
Weight in the ten largest positions	77.6%
Largest single position	23.5%
Assets under management	$1.7B

Expense ratio, yield and assets are reference data; every other figure is computed here from weekly closes.

How it moves with the market

Against	Correlation, 3 years	Covariance, annualised, in percent squared
SPY	0.39barely linked	94
QQQ	0.23barely linked	74

Weekly total returns. What the bands mean · why the covariance is printed.

Year by year

Year	Total return
2026	24.2%
2025	31.7%
2024	8.1%
2023	1.1%
2022	-4.9%

One year

IHE 150 SPY 118

2025-09-122026-09-04

IHE rebased to 100 a year ago, weekly closes, prices through 2026-09-04.

Where to go next

IHF, iShares U.S. Healthcare Providers ETF
IHI, iShares U.S. Medical Devices ETF
IXJ, iShares Global Healthcare ETF
IYH, iShares U.S. Healthcare ETF
Run a portfolio x-ray to see what IHE carries once you look through it
Compare IHE against any other fund in the builder

Holdings from the issuer file published 2026-09-03. Prices through 2026-09-04. How every figure here is produced. Measurements, not investment advice.